Boston, US and Rolle, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that its SOPHiA DDM™ Platform is now CE marked under the European Union’s In Vitro Diagnostic Regulation (IVDR). IVDR certification is a significant regulatory milestone that validates the powerful analytical capabilities of the SOPHiA […]

MOUNTAIN VIEW, Calif., and MIAMI LAKES, Fla. — DNAnexus, Inc., provider of the Precision Health Data Cloud, and Galatea Bio, committed to ‘Precision Health at Scale for All,’ today announced a strategic collaboration to enhance biomedical research and precision medicine, particularly for Latin American populations and other underserved groups. The collaboration will combine Galatea’s specialized […]

Bioinformatics — We are excited to announce the release of OmicsBox 3.3, the All-In-One bioinformatics software, designed to simplify your research. This latest version integrates a range of new features and improvements, offering improved usability, advanced functionalities, and expanded database support to meet the diverse needs of the bioinformatics community. With a focus on providing […]

Cambridge, UK – Cresset, an innovative provider of integrated in silico solutions for drug discovery, announces an extension of the global collaboration with Enamine, the world’s leading chemical and biological contract research organization and producer of novel building blocks for drug design, in the area of targeted protein degradation (TPD). TPD is an exciting research […]

Major software release enables breeding and crop protection organizations to automate and scale up R&D workflows via a single digital platform Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biotechnology R&D, today announced a new release of Genedata Selector®️, an end-to-end platform that enables agricultural biotechnology organizations to develop innovative seeds […]

Global biopharma leader drives digital innovation, data sciences, and next-generation automation approaches with Genedata’s cloud-based Biopharma Platform Basel, Switzerland — Genedata, a leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that GSK, a leading biopharma company, has extended the use of Genedata Biologics®️; to new application areas in data sciences, analytics, and […]

The hospital will use the SOPHiA DDM™ Platform to enhance its testing and research of blood cancers BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, today announced that L’hôpital Universitaire Avicenne is implementing the SOPHiA DDM™ Platform. The hospital, located in Bobigny, France, will use the […]

LAUSANNE, Switzerland — Saphetor SA, the creators of the global human genetics community VarSome, today announced European CE mark approval of the VarSome Clinical platform for the automated variant discovery, annotation, and interpretation of Next Generation Sequencing (NGS) data in compliance with the European Union’s In-Vitro Diagnostic Medical Devices Regulation (IVDR) (EU Regulation 2017/746 on IVD […]

OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, announced today that OncoHelix, an internationally recognized research and diagnostics laboratory for precision diagnostics, will implement MSK-ACCESS® powered with SOPHiA DDM™. The organization, which currently uses the SOPHiA […]

New funding will expand CytoReason’s disease models and proprietary data, enabling R&D leaders at partner companies to make strategic decisions with greater speed and precision. CytoReason will use this investment to expand the application of its models into additional indications, grow its proprietary molecular and clinical data, and establish an office in Cambridge, Massachusetts later […]